Companion Diagnostics Oncology Market to Reach USD 12.31 Billion by 2034 as Precision Cancer Care Expands According to a report published by OG Analysis, the Companion Diagnostics Oncology Market is valued at USD 5.11 billion in 2026 and is projected to reach USD 12.31 billion by 2034, growing at a CAGR of 11.61%. Increasing biomarker-guided cancer treatment, targeted therapies and advanced...